Keywords: HCV, hepatitis C virus; DAA, direct-acting antiviral; TPV, telaprevir; BOC, boceprevir; SMV, simeprevir; SOF, sofosbuvir; DSV, dasabuvir; LDV, ledipasvir; DCV, daclatasvir; OBV, ombitasvir; GT, genotype; RBV, ribavirin; PI, protease inhibitor; PTV/r, pari
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failure
Keywords: HCV, hepatitis C virus; GT, genotype; PIs, protease inhibitors; TLP, telaprevir; BOC, boceprevir; PEG-IFN, pegylated-interferon; RBV, ribavirin; SVR, sustained virologic response; DAAs, direct-acting antivirals; RAVs, resistance associated variants; UDPS,
Assessment of two multilocus sequence typing (MLST) schemes available for Streptococcus mutans
Keywords: MLST, multilocus sequence typing; rep-PCR, repetitive extragenic palindromic polymerase chain reaction; NS, Nakano MLST typing scheme; DS, Do MLST typing scheme; bp, base pair; ST, sequence type; GT, genotype; GG, genotype groups; IA, index of association
Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir
Keywords: ART, Abbott RealTime HCV; CAP, Roche AmpliPrep COBAS® TaqMan® HCV v2.0; DAA, direct-acting antiviral agent; GT, genotype; HCV, hepatitis C virus; HPS, Roche High-Pure-System COBAS® TaqMan® HCV v2.0; LLOQ, lower limit of quantification; LOD, limit of detec
Molecular epidemiology of Hepatitis B virus in Córdoba, Argentina
Keywords: HBV, hepatitis B virus; HIV, human immunodeficiency virus; BCP-pC, basal core promoter-precore; HBsAg, hepatitis B surface antigen; gt, genotype; sgt, subgenotype; HBc, hepatitis B core protein; IgM, immunoglobulin M; HBeAg, hepatitis B “e” antigen; DNA,
Intertypic modular exchanges of genomic segments by homologous recombination at universally conserved segments in human adenovirus species D
Keywords: HAdV, human adenovirus; HAdV-D, human adenovirus species D; GT, genotype; dS, synonymous substitution rate; UCSs, universally conserved segments; MHC, major histocompatibility complex; INSDC, International Nucleotide Sequence Database Collaboration; MGA,
RNA-dependent RNA polymerases from different hepatitis C virus genotypes reveal distinct biochemical properties and drug susceptibilities
Keywords: HCV, hepatitis C virus; GT, genotype; NS5B, non-structure protein 5B (RNA-dependent RNA polymerase); NNI, non-nucleoside polymerase inhibitorHCV; NS5B; Genotype; RNA polymerase; Non nucleoside inhibitor
Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection
Keywords: Drug; Clinical Trial; Direct-Acting Antivirals; Peginterferon-FreeAE, adverse event; DAA, direct-acting antiviral agent; GT, genotype; LLOD, lower limit of detection; LLOQ, lower limit of quantification; NI, nucleoside polymerase inhibitor; NNI, non-nucle
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins
Keywords: Correlates of Protection; Viral Kinetics; ELISPOT ResponsesELISPOT, enzyme-linked immunospot; GT, genotype; HCV, hepatitis C virus; HIV, human immunodeficiency virus; IQR, interquartile range; NS, nonstructural; NTR, nontranslated region; RdRp, RNA-depend
Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay
Keywords: EIA, enzyme immunoassay; GT, genotype; HCV, hepatitis C virus; HCVcoreAg, HCV-core antigen; NAT, nucleic acid testingHCV-core antigen assay; HCV-RNA; Hepatitis C; Performance; Stability; Correlation